Incidence of intermediate syndrome in organophosphorous poisoning.

Simple item page
dc.contributor.authorSamuel, Jen_US
dc.contributor.authorThomas, Ken_US
dc.contributor.authorJeyaseelan, Len_US
dc.contributor.authorPeter, J Ven_US
dc.contributor.authorCherian, A Men_US
dc.date.accessioned1995-05-01en_US
dc.date.accessioned2009-05-30T23:45:54Z
dc.date.available1995-05-01en_US
dc.date.available2009-05-30T23:45:54Z
dc.date.issued1995-05-01en_US
dc.description.abstractSeventy two patients admitted to the Intensive Care Unit following ingestion of organophosphorus compounds were studied prospectively with two different doses of pralidoxime (PAM). One group received 1 gm immediately after admission and no further PAM and the other group received infusion of PAM, 1 gm 8 hourly for four days (total 12 gms). The incidence of type II paralysis or intermediate syndrome was 47%. We observed a higher incidence in the 4 days of infusion of PAM group (61%) (20 patients) as compared to the single Bolus dose group (39%) (13 patients). Relative risk 1.48 (confidence interval = 0.9-2.4).en_US
dc.description.affiliationDepartment of Medicine, Christian Medical College & Hospital, Tamil Nadu.en_US
dc.identifier.citationSamuel J, Thomas K, Jeyaseelan L, Peter JV, Cherian AM. Incidence of intermediate syndrome in organophosphorous poisoning. Journal of the Association of Physicians of India. 1995 May; 43(5): 321-3en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/90713
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAdulten_US
dc.subject.meshCholinesterase Reactivators --administration & dosageen_US
dc.subject.meshDose-Response Relationship, Drugen_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshDrug Administration Scheduleen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfusions, Intravenousen_US
dc.subject.meshMaleen_US
dc.subject.meshOrganophosphorus Compounds --poisoningen_US
dc.subject.meshOverdose --drug therapyen_US
dc.subject.meshParalysis --chemically induceden_US
dc.subject.meshPralidoxime Compounds --administration & dosageen_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshRespiratory Paralysis --chemically induceden_US
dc.subject.meshSyndromeen_US
dc.titleIncidence of intermediate syndrome in organophosphorous poisoning.en_US
dc.typeClinical Trialen_US
dc.typeComparative Studyen_US
dc.typeJournal Articleen_US
dc.typeRandomized Controlled Trialen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Association of Physicians of India